Product Overview
ID Components Size (96 tests)
ISK-024-1 High-bind Plate 1 plate
ISK-024-2 Human IL-7 R alpha & TSLP R 25 μg
ISK-024-3 Anti- TSLP Neutralizing Antibody 20 μg
ISK-024-4 Human TSLP-Biotin 10 μg
ISK-024-5 Streptavidin-HRP 10 μg
ISK-024-6 Coating Buffer 12 mL
ISK-024-7 10xWashing Buffer 50 mL
ISK-024-8 Blocking Buffer 50 mL
ISK-024-9 Substrate Solution 12 mL
ISK-024-10 Stop Solution 7 mL
Description
Thymic stromal lymphopoietin (TSLP) exerts its biological effects by binding to a high-affinity heteromeric complex composed of thymic stromal lymphopoietin receptor chain and IL-7Rα.The formation of the ternary complex, TSLPR:TSLP: IL-7Rα,initiates signaling in cells co-expressing TSLPR and IL-7Rα.TSLP has been implicated in a variety of allergic diseases (e.g., atopic dermatitis, bronchial asthma, eosinophilic esophagitis). Therefore, inhibition of TSLP interaction with TSLP receptor complex has been considered a promising strategy to blocks thymic stromal lymphopoietin (TSLP) function and prevents the overreactive immune response to allergic,eosinophilic and other types of airway inflammation associated with severe asthma.
Assay Principles
This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new TLSP pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human TLSP to immobilized human IL-7 R alpha & TSLP R in a functional ELISA assay, and employs a simple colorimetric sandwich ELISA platform.
Your experiment will include 4 simple steps:
a) Coat the plate with human IL-7 R alpha & TSLP R.
b) Add your molecule of interest to the tests.
c) Add human TLSP-Biotin to bind the coated human IL-7 R alpha & TSLP R.
d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.
Finally, the ability of your compound to inhibit TSLP: IL-7 R alpha & TSLP Rbinding will be determined by comparing OD readings among different experimental groups.